Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis
- PMID: 15781611
- DOI: 10.1158/0008-5472.CAN-04-3157
Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis
Abstract
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a cytosolic protein that catalyzes metabolic detoxification of quinones and protects cells against redox cycling and oxidative stress. NQO1-null mice deficient in NQO1 protein showed increased sensitivity to 7,12-dimethylbenz(a)anthracene- and benzo(a)pyrene-induced skin carcinogenesis. In the present studies, we show that benzo(a)pyrene metabolite benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide and not benzo(a)pyrene quinones contributed to increased benzo(a) pyrene-induced skin tumors in NQO1-null mice. An analysis of untreated skin revealed an altered intracellular redox state due to accumulation of NADH and reduced levels of NAD/NADH in NQO1-null mice as compared with wild-type mice. Treatment with benzo(a)pyrene failed to significantly increase p53 and apoptosis in the skin of NQO1-null mice when compared with wild-type mice. These results led to the conclusion that altered intracellular redox state along with lack of induction of p53 and decreased apoptosis plays a significant role in increased sensitivity of NQO1-null mice to benzo(a)pyrene-induced skin cancer.
Similar articles
-
Inactivation of the quinone oxidoreductases NQO1 and NQO2 strongly elevates the incidence and multiplicity of chemically induced skin tumors.Cancer Res. 2010 Feb 1;70(3):1006-14. doi: 10.1158/0008-5472.CAN-09-2938. Epub 2010 Jan 26. Cancer Res. 2010. Retraction in: Cancer Res. 2018 Nov 1;78(21):6345. doi: 10.1158/0008-5472.CAN-18-2453. PMID: 20103645 Free PMC article. Retracted.
-
NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis.Cancer Res. 2000 Nov 1;60(21):5913-5. Cancer Res. 2000. PMID: 11085502
-
Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis.Cancer Res. 2004 Sep 1;64(17):5925-8. doi: 10.1158/0008-5472.CAN-04-0763. Cancer Res. 2004. PMID: 15342368
-
Functions of NQO1 in Cellular Protection and CoQ10 Metabolism and its Potential Role as a Redox Sensitive Molecular Switch.Front Physiol. 2017 Aug 24;8:595. doi: 10.3389/fphys.2017.00595. eCollection 2017. Front Physiol. 2017. PMID: 28883796 Free PMC article. Review.
-
Natural Source of Drugs Targeting Central Nervous System Tumors-Focus on NAD(P)H Oxidoreductase 1 (NQO1) Activity.Brain Sci. 2025 Jan 29;15(2):132. doi: 10.3390/brainsci15020132. Brain Sci. 2025. PMID: 40002465 Free PMC article. Review.
Cited by
-
Genetic evidence for NAD(P)H:quinone oxidoreductase 1-catalyzed quinone reduction on passage through the mouse pulmonary circulation.Am J Physiol Lung Cell Mol Physiol. 2011 May;300(5):L773-80. doi: 10.1152/ajplung.00394.2010. Epub 2011 Feb 4. Am J Physiol Lung Cell Mol Physiol. 2011. PMID: 21296895 Free PMC article.
-
Phytochemicals for the Prevention of Photocarcinogenesis.Photochem Photobiol. 2017 Jul;93(4):956-974. doi: 10.1111/php.12711. Epub 2017 Mar 14. Photochem Photobiol. 2017. PMID: 28063168 Free PMC article. Review.
-
Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells.Free Radic Biol Med. 2009 Jan 1;46(1):25-32. doi: 10.1016/j.freeradbiomed.2008.09.007. Epub 2008 Sep 20. Free Radic Biol Med. 2009. PMID: 18848878 Free PMC article.
-
Inactivation of the quinone oxidoreductases NQO1 and NQO2 strongly elevates the incidence and multiplicity of chemically induced skin tumors.Cancer Res. 2010 Feb 1;70(3):1006-14. doi: 10.1158/0008-5472.CAN-09-2938. Epub 2010 Jan 26. Cancer Res. 2010. Retraction in: Cancer Res. 2018 Nov 1;78(21):6345. doi: 10.1158/0008-5472.CAN-18-2453. PMID: 20103645 Free PMC article. Retracted.
-
Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer.Oncogene. 2012 Oct 4;31(40):4362-71. doi: 10.1038/onc.2011.600. Epub 2012 Jan 16. Oncogene. 2012. Retraction in: Oncogene. 2017 May 18;36(20):2920. doi: 10.1038/onc.2016.476. PMID: 22249251 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous